|Articles|June 1, 2019
- Applied Clinical Trials-06-01-2019
- Volume 28
- Issue 6
Applied Clinical Trials, June 2019 Issue (PDF)
Click the title above to open the Applied Clinical Trials June 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 6 years ago
Master Protocol Guidance in Cancer R&D: Impact on Industryover 6 years ago
The Benefits of RWD & RWE in Oncology Trialsover 6 years ago
Glimpsing the Future of Clinical Trial Designover 6 years ago
FDA Facilitates Expanded Access for Cancer Drugsover 6 years ago
News Notesover 6 years ago
Navigating Drug Development Through More Turbulent Watersover 6 years ago
Building a Physician Referral Network: A Case Studyover 6 years ago
Reveling in 2018's Revealing Drug and Biologic ApprovalsNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Slower FDA Guidance Pushes Sponsors Toward Legacy Approaches
2
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
3
Global by Design: What 2026 Means for Sites, Sponsors, and Trial Operations
4
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
5